Cicada COVID Variant: The Silent Comeback That’s Raising Global Concerns

The devastating COVID-19 pandemic first emerged in January 2020, caused by the virus known as SARS-CoV-2. It led to immense global suffering, claiming countless lives and disrupting societies worldwide. In March 2020, the World Health Organization (WHO) declared COVID-19 a Global Health Emergency, a status that remained in place until May 2023.

The Virus Has Been Quiet—Not Gone

Even as life began returning to normal, the virus continued to evolve in the background. According to global health agencies like the Centers for Disease Control and Prevention, viral mutations are a natural process that allows pathogens to adapt and survive.

A mutation is simply a change in the virus’s genetic structure. Sometimes it weakens the virus, but at other times it helps it become more resilient. Viruses such as COVID-19, influenza, and HIV are particularly known for frequent mutation.

One Variant Leads to Another

In 2021, the Omicron variant emerged and quickly spread across the globe. Early reports tracked by the World Health Organization highlighted its rapid transmissibility and evolving subvariants.

Over time, Omicron gave rise to multiple subvariants including BA.1, BA.2, BA.3, BA.4, and BA.5. From this chain, BA.3 evolved further into BA.3.2—demonstrating once again how the virus continues to adapt.

Recommended Articles

Children Don’t Fail — Teaching Methods Fail Them: Why the real problem in classrooms isn’t the child, but how we teach

Written by Dr. Ramakrishna Biswal · Updated at: Apr 28, 2026

Dubai Economy After Iran Attack: Is It Still Safe for Investors?

Written by Sheena Ricarte · Updated at: Apr 28, 2026

From Sea Voyages to Science: How Scurvy Shaped Human History

Written by Dr. Raj Kishore Panda · Updated at: Apr 28, 2026

A Tiny Protein, A Big Role

At the center of this evolution is the spike protein—the mechanism that allows the virus to enter human cells. As noted by the Centers for Disease Control and Prevention, most COVID-19 vaccines are designed to target this specific protein.

Changes in this structure can influence how easily the virus spreads and how effectively the immune system responds.

Why “Cicada”? There’s a Reason

The BA.3.2 variant, now being referred to as “Cicada,” was first reported in South Africa in 2024. After a period of relative inactivity, it began spreading again in the United States, according to preliminary observations discussed in global surveillance updates.

The name draws a parallel with the cicada insect, known for disappearing for long periods before suddenly reappearing—an unsettling similarity.

Also Read:  From Sea Voyages to Science: How Scurvy Shaped Human History

It’s Already Knocking on Doors

While not yet dominant globally, early data from European health monitoring agencies such as the European Centre for Disease Prevention and Control suggest that emerging variants continue to account for a share of recent infections.

Cicada’s presence in multiple regions is a reminder that new waves often begin quietly.

Feels Familiar… And That’s the Risk

The symptoms linked to this variant remain similar to earlier COVID-19 strains—cold, cough, headache, and body pain. Health advisories from the Centers for Disease Control and Prevention continue to emphasize caution even when symptoms appear mild.

Familiarity can often lead to underestimation.

Also Read: From Books to Reels: Endless Scrolling Is Silently Damaging Your Child’s Brain

Vaccines Still Have Our Back

Current vaccines remain the primary defense. Experts suggest that variants within the Omicron lineage are still likely to be covered by updated vaccines.

As William Schaffner notes, vaccines developed for Omicron subvariants are expected to offer protection against BA.3.2 as well. Guidance from the World Health Organization continues to support vaccination as the most effective preventive tool.

Testing Isn’t Failing Us—Yet

Existing COVID-19 diagnostic tests remain effective. According to the Centers for Disease Control and Prevention, the regions of the virus targeted by standard tests are less prone to rapid mutation.

This ensures continued reliability in detection, at least for now.

The Real Danger? Forgetting Too Soon

Perhaps the biggest risk is not just the virus—but complacency. Even as the world moves forward, health authorities including the World Health Organization continue to stress vigilance.

Cicada may not yet be a global threat, but it is a reminder: the story of COVID-19 is still unfolding.